Cathy Petti, MD

Dr. Petti is a health technology executive and diagnostics expert with a unique combination of clinical, scientific and operational expertise, focusing her efforts on the molecular diagnostics, genomics and digital health verticals. She is founder and CEO, HealthSpring Global, a niche consulting firm supporting companies in their strategic corporate activities related to technology assessments, clinical trial and regulatory strategies, top-down and ground-up market research, and pathways to commercialization. She has assisted numerous companies across the value-add chain, successfully facilitating private equity financings, government contracts and merger and acquisition transactions.

​

Among her prior senior executive roles, Dr. Petti served as Global Head at Novartis Diagnostics where she was responsible for expanding global markets for their core products and building R&D teams for three de novo franchises. As Chief Health Officer at Ancestry, Dr. Petti built a direct-to-consumer genetic testing portfolio and served on the executive team that led to private equity investments at enterprise value of $2.6 billion. She also led ARUP Infectious Diseases Laboratory, one of the country’s largest infectious diseases laboratories and pioneered research in DNA sequencing.

​

She is also deeply involved in global health initiatives that promote better diagnostics and greater test access in resource constrained regions. Dr. Petti holds an AB from Harvard University and MD from Duke University.